Search
Neuropace Inc
NPCEAdd to Watchlist
6.410USD
-5.610-46.67%
Market hours 11/13, 14:32（ET）
219.99MMarket Cap
LossP/E TTM
Neuropace Inc (NPCE) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Neuropace Inc in the past month.
Buy
2 Strong Buy
7 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
19.778USD+60.79%
NPCE Analyst Recommendation Trends
In the current month, NPCE has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NPCE average Analyst price target in the last month is 19.778.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
2
2
2
2
2
7
7
7
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
9
8
8
8
8
8
NPCE Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, NPCE EPS is projected to reach -0.076 in FY2026Q4, following reported EPS of -0.096 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.22
-0.21
-0.09
-0.08
-0.10
Actual
-0.20
-0.18
-0.10
--
--
Surprise
+11.33%
+12.04%
-6.69%
--
--
FAQs
What is Neuropace Inc's expected revenue for the next quarter?
Neuropace Inc's expected revenue is 28.40M.
What is Neuropace Inc's price target?
Analysts forecast that Neuropace Inc's price target is USD 19.78, with the highest forecast at USD 22.00 and the lowest forecast at USD 18.00.
How have Neuropace IncNPCE's recent earnings per share performed?
The market expectation was USD -0.10, while Neuropace IncNPCE's earnings per share (EPS) for the previous quarter was USD -0.18. EPS for the next quarter is expected at USD -0.08.
What is the analyst rating for Neuropace Inc?
Based on the ratings of Neuropace Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.